Stark & Stark is no longer accepting inquiries for this litigation. For an updated list of our current cases, visit our homepage.
Xarelto (rivaroxaban) is a blood thinner that was approved by the FDA in July 2011 to prevent strokes. In November 2011, the approval was expanded to any patients with atrial fibrillation (irregular heartbeat). Xarelto has been widely prescribed, with millions of people taking the medication since it entered the market.
Xarelto is marketed as an anticoagulant prescribed to reduce the risk of atrial fibrillation (AFib), stroke, deep-vein thrombosis (DVT), and pulmonary embolism (PE). It is manufactured in the United States by Bayer and Johnson & Johnson’s New Jersey-based division, Janssen Pharmaceuticals.
Marketing efforts claim that Xarelto is safer than warfarin, another anticoagulant but recent studies suggest otherwise. Bleeding risks and other side effects common to blood thinners were found to be nearly identical. One selling point put forth by the manufacturer for switching to Xarelto is that it does not require the frequent blood draws that Warfarin requires to ensure appropriate levels of the drug in the patient; however, experts have opined that is not accurate.
Since its approval, there have been numerous reports of increased risk of injury when taking Xarelto, including, but not limited to:
These events can be life threatening since, unlike warfarin, there is no approved antidote for Xarelto to stop the bleeding.
Stark & Stark’s Mass Tort team pursues claims against drug manufacturers so they can be held liable when the drugs they market are proven to be defective and cause injury to the people who use them. Our Xarelto lawsuit lawyers are experienced in mass torts MDL litigation cases and in negotiating with pharmaceutical settlement representatives. If you or a member of your family has suffered an injury from Xarelto use, you may be entitled to compensation under the MDL litigation process or via settlement.
Please contact Stark & Stark to speak with one of the Xarelto attorneys, free of charge, who can help assess any claims that you may have and to help you understand the settlement and lawsuit process.
Stark & Stark Attorneys Recognized as New Jersey “Super Lawyers” and “Rising Stars” in 2026
Stark & Stark is pleased to announce that 15 of its attorneys have been selected for inclusion in the list of 2026 New Jersey Super Lawyers,...Bruce Stern, Esq. Secures $1,000,000 Settlement in Motor Vehicle Collision Case
Bruce Stern, Esq. recently secured a $1,000,000 settlement in a motor vehicle collision case.* “This case highlights how quickly things can go...Deborah Dunn, Esq. Elected to Board of Directors for Angel Flight East
Stark & Stark is pleased to announce that Deborah Dunn, Esq., Shareholder and Civil Trial Attorney, has been elected to the Board of Directors...Michael Jordan, Esq. Joins the Board of the Lawrence Township Community Foundation
It is our pleasure to announce that Michael Jordan, Esq. has joined the board of the Lawrence Township Community Foundation, an organization...Joseph Lemkin, Esq. Named to ROI-NJ Influencers: Power List 2026 – Law
Stark & Stark is proud to share that Joseph Lemkin, Esq., Shareholder, has been named to the 2026 Influencers: Power List in the Law category...Joseph Cullen, Esq. and Nicole Durso, Esq. Secure $2,000,000 Settlement in Personal Injury Matter
Joseph Cullen, Esq. and Nicole Durso, Esq. recently secured a $2,000,000 settlement in a personal injury matter involving a pedestrian who was struck...James Creegan, Esq. Appointed to Board of The 200 Club of Mercer County
It is our pleasure to announce that James Creegan, Esq. has been appointed to the Board of Directors of The 200 Club of Mercer County, an...
